TrialScientific reports2019
Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer.
Akiko Tsujimoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
TrialScientific reports2019
Akiko Tsujimoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.